Stock MarketROI
Open
ALGN

ALGN

Healthcare · Medical Instruments & Supplies

$180.26+1.12%
Mkt Cap: $12.91B

Performance

ALGN (ALGN) Stock Analysis 2026

Rule-based · Updated daily · Not financial advice

ALGN (ALGN) operates in the Medical Instruments & Supplies space within the Healthcare sector. With a market cap of $12.9B, it qualifies as a mid-cap company. Growth is moderate and the business remains profitable, offering a balanced risk/reward profile compared to high-multiple peers.

Bull Case4
  • Forward P/E (14.6×) is lower than trailing P/E (30.3×) — analysts expect earnings to improve
  • Revenue growth of 6% YoY shows solid business momentum
  • Earnings grew 24% YoY — bottom-line is expanding fast
  • Healthy profit margin of 10.5%
Bear Case4
  • P/E of 30.3× is above average — valuation requires continued strong growth to justify
  • High debt-to-equity of 2.80× increases financial risk, especially with elevated interest rates
  • No dividend history — total return depends entirely on price appreciation
  • High beta of 1.67 — this stock is significantly more volatile than the broader market

Verdict

Hold

Mixed signals — strengths and risks roughly balance. Wait for a clearer catalyst.

AI Insight

Powered by Claude

AI-generated analysis for informational purposes only. Not financial advice.

Related Articles

Revenue & Results

Dividends

This stock does not pay dividends.

If You Had Invested…

Hypothetical return based on historical prices

$

* Dividend reinvestment calculated at ex-date price. For informational purposes only.

Earnings

Next Earnings

Jul 29, 2026

43

days

EPS (TTM)

$5.95

P/E (TTM)

30.3

Fwd P/E

14.6

Earnings History

SEC EDGAR · official filings

SEC filings

SEC Filings

Official EDGAR documents

All filings

Key Statistics

Valuation

Market Cap$12.91B
P/E Ratio30.30
Forward P/E14.57
P/B Ratio
PEG Ratio0.92
EPS (TTM)$5.95

Trading

Open
Day High
Day Low
52W High$208.31
52W Low$122.00
Volume
Avg Volume (3M)1,060,709
Beta1.67

Dividends

Dividend Yield
Annual Rate
Ex-Div Date
Payout Ratio0.00%

Profitability

Profit Margin10.50%
Operating Margin16.59%
ROE10.82%
ROA7.33%
Revenue Growth6.20%
Earnings Growth23.90%

Balance Sheet

Total Revenue$4.10B
Total Debt$116.04M
Debt / Equity2.80
Current Ratio1.39
Free Cash Flow$538.98M

Fair Value Estimates

Current price: $180.26

Graham Number

√(22.5 × EPS × Book Value)

$88.07

-51.1% downside

Benjamin Graham's intrinsic value formula. Assumes a fair stock trades at no more than 22.5× the product of EPS and book value per share.

Bazin Ceiling Price

Avg. Annual DPS (5Y) ÷ 6%

N/A

Décio Bazin's dividend-based ceiling. The max price you should pay so that dividends alone deliver at least 6% annual yield on your cost basis.

These are simplified estimates. Not financial advice.

Buy & Hold Checklist

Quality criteria for long-term holding

6/10

75% score

Pays dividends

No dividend history found

Dividend consistency (5Y+)

Uninterrupted dividend payments for at least 5 years

ROE above 10%

10.8%

Return on equity — measures how efficiently capital is used

Positive profit margin

10.5%

Net profit margin must be positive — company earns more than it spends

Revenue growth (annual)

+6.2%

Annual revenue must be growing compared to the prior year

Earnings growth (annual)

+23.9%

Annual earnings must be growing compared to the prior year

Debt/Equity below 2×

2.80×

Low financial leverage reduces risk of distress

Current ratio above 1

1.39×

Short-term assets must cover short-term liabilities

Daily liquidity above $5M

$191M/day

High trading volume ensures easy entry and exit

Dividend yield above 0%

Stock must distribute income to shareholders

Related Assets

Healthcare

About ALGN

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

Sector

Healthcare

Industry

Medical Instruments & Supplies

Location

Tempe, United States

Employees

20,275